ArticleInternational journal of general medicine2026
Post-Treatment Partial Pressure of Carbon Dioxide for Prognostic Stratification and Non-Invasive Ventilation Guidance in Elderly Patients with Community-Acquired Pneumonia and Heart Failure: The "Subgroup with Impaired Cardiac Response".
Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prognostic stratification in elderly patients with co-existing community-acquired pneumonia (CAP) and heart failure (HF) is challenging due to the limitations of static admission scores. Objective : To evaluate the prognostic value of the 72-hour post-admission partial pressure of carbon dioxide (PCO2_post) and its utility in guiding non-invasive ventilation (NIV) therapy. Methods: We analyzed 100 elderly patients with CAP and HF. Six-month mortality was the primary endpoint. Propensity score matching (PSM) was used to explore mechanistic differences between risk strata. Results: PCO2_post was a potent exploratory predictor of 6-month mortality (AUC=0.968), comparable to the Pneumonia Severity Index (AUC=0.960). A threshold of 47-48 mmHg stratified patients into two distinct risk groups (HR 23.55, P < 0.001). NIV significantly reduced HF events and accelerated symptom resolution only in the low-risk group (PCO2_post < 47mmHg). PSM analysis revealed that high-risk patients (PCO2_post mmHg ≥ 47) exhibited a "subgroup with impaired cardiac response", characterized by paradoxical BNP increases (median +1722.9 pg/mL), persistent inflammation (higher CRP), and slow clinical recovery. Conclusion: PCO2_post is a pragmatic dynamic biomarker that identifies a specific subgroup with impaired cardiac response who derive limited benefit from NIV, suggesting the need for intensified clinical monitoring and consideration of alternative therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.